Oaktree Acquisition Corp. III Life Sciences Stock (NASDAQ:OACC)


OwnershipFinancialsChart

Previous Close

$10.44

52W Range

$9.95 - $10.85

50D Avg

$10.28

200D Avg

$10.13

Market Cap

$256.64M

Avg Vol (3M)

$97.79K

Beta

-0.22

Div Yield

-

OACC Company Profile


Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Dec 16, 2024

Website

OACC Performance


OACC Financial Summary


Dec 24
Revenue-
Operating Income$-703.61
Net Income$2.66K
EBITDA-
Basic EPS-
Diluted EPS-

Fiscal year ends in Dec 24 | Currency in USD